CSF1R and melanoma: To assess this, we employed an anti-colony-stimulating factor 1 receptor (CSF1R) antibody to deplete macrophages in vivo before orthotopically implanting B16-OVA-β2mKO tumors into the flanks of mice16 (a subcutaneous melanoma model was used here to eliminate microglia as a confounding population).